NCBI PubMed Central
open access
Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Lenalidomide for Patients With Myelofibrosis (MF)#891251
- Pulmonary fibrosis: Emerging targets and novel therapeutics.#285103
- Fibrosis: cross-organ biology and pathways to development of innovative drugs.#280903
- Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis#873904
- A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis#877680
Record · ID 1158876
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive